Glycated haemoglobin in diabetic women with and without HIV infection: Data from the Women's Interagency HIV Study

Antiviral Therapy

Volumn 15, Issue 4, 2010, Pages 571-577

  Glesby, Marshall J ^a   Hoover, Donald R ^b   Shi, Qiuhu ^c   Danoff, Ann ^d   Howard, Andrea ^e   Tien, Phyllis ^f,g   Merenstein, Dan ^h   Cohen, Mardge ^i,j   Golub, Elizabeth ^k   DeHovitz, Jack ^l   Nowicki, Marek ^m   Anastos, Kathryn ⁿ  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Mailman School of Public Health ^*  (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

ⁱ Jr Hospital of Cook County   (United States)

^j RUSH MEDICAL COLLEGE   (United States)

^k JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^l SUNY DOWNSTATE MEDICAL CENTER   (United States)

^m UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁿ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; STAVUDINE; ZIDOVUDINE; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; DIABETES MELLITUS; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR VOLUME; PRIORITY JOURNAL; VIREMIA; ANALYSIS; COHORT ANALYSIS; COMPLICATION; DRUG EFFECTS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MIDDLE AGED; VIROLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLOOD GLUCOSE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED;

EID: 77956797789     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1557     Document Type: Article

References (17)

1. Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005; 165:1179-1184. (Pubitemid 40720744)
2. Tien PC, Schneider MF, Cole SR, et al. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study. AIDS 2007; 21:1739-1745.
3. Samaras K. Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy. J Acquir Immune Defic Syndr 2009; 50:499-505.
4. Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 2006; 295:1688-1697.
5. Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 2002; 137:263-272.
6. The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32:1327-1334.
7. Polgreen PM, Putz D, Stapleton JT. Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus. Clin Infect Dis 2003; 37:e53-e56.
8. Diop ME, Bastard JP, Meunier N, et al. Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients. AIDS Res Hum Retroviruses 2006; 22:1242-1247.
9. Kim PS, Woods C, Georgoff P, et al. Hemoglobin A1c underestimates glycemia in HIV infection. Diabetes Care 2009; 32:1591-1593.
10. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998; 9:117-125.
11. Bacon MC, von Wyl V, Alden C, et al. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 2005; 12:1013-1019.
12. Strickler HD, Howard AA, Peters M, et al. The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women. AIDS 2008; 22:527-531.
13. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001; 47:1985-1992.
14. Bleyer AJ, Hire D, Russell GB, et al. Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobin. Diabet Med 2009; 26:128-133.
15. Bloomgarden ZT, Inzucchi SE, Karnieli E, Le Roith D. The proposed terminology 'A(1c)-derived average glucose' is inherently imprecise and should not be adopted. Diabetologia 2008; 51:1111-1114.
16. Soonthornpun S, Rattarasarn C, Leelawattana R, Setasuban W. Postprandial plasma glucose: a good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels. Diabetes Res Clin Pract 1999; 46:23-27. (Pubitemid 29474998)
17. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care 2009; 32 Suppl 1:S13-S61.